, Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative: ACR/EULAR Classification Criteria for SSc, Arthritis & Rheumatism, vol.65, pp.2737-2747, 2013.
, The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms, Rheumatol Int, vol.37, pp.1303-1310, 2017.
, Sirtuin1 Protects against Systemic Sclerosis-related Pulmonary Fibrosis by Decreasing Proinflammatory and Profibrotic Processes, Am J Respir Cell Mol Biol, vol.58, pp.28-39, 2018.
, Identification of CD146 as a novel molecular actor involved in systemic sclerosis, Journal of Allergy and Clinical Immunology, vol.140, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01778289
, CD146: biosynthesis and production of a soluble form in human cultured endothelial cells, FEBS Letters, vol.421, pp.12-14, 1998.
, S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen, Tissue Antigens, vol.48, pp.531-539, 1996.
, Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion, Blood, vol.98, pp.3677-3684, 2001.
, CD146 and its Soluble Form Regulate Monocyte Transendothelial Migration, ATVB, vol.29, pp.746-753, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00428932
, CD146 Short Isoform Increases the Proangiogenic Potential of Endothelial Progenitor Cells In Vitro and In Vivo, Circulation Research, vol.107, pp.66-75, 2010.
, Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease, Inflammatory Bowel Diseases, vol.12, pp.16-21, 2006.
, Elevated serum levels of soluble CD146 in patients with systemic sclerosis, Clin Rheumatol, vol.36, pp.119-124, 2017.
, Detection of the Cancer Marker CD146 Expression in Melanoma Cells with Semiconductor Quantum Dot Label, j biomed nanotechnol, vol.6, pp.303-311, 2010.
, Identification of soluble CD146 as a regulator of trophoblast migration: potential role in placental vascular development, Angiogenesis, vol.16, pp.329-342, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02385712
, Relationship of CD146 expression to secretion of interleukin (IL)-17, IL-22 and interferon-? by CD4 + T cells in patients with inflammatory arthritis: Cytokine secretion by CD146 + CD4 + T cells, Clin Exp Immunol, vol.179, pp.378-391, 2015.
, ROR?t and ROR? signature genes in human TH17 cells, PLoS One, vol.12, p.181868, 2017.
, IL-17 family: Cytokines, receptors and signaling, Cytokine, vol.64, pp.477-485, 2013.
, IL-17 and TH17 cells in systemic sclerosis: a comprehensive review, Romanian Journal of Internal Medicine, vol.55, pp.198-204, 2017.
, IL-17 Signaling: The Yin and the Yang, Trends in Immunology, vol.38, pp.310-322, 2017.
, The elevated expression of TH17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis, Human Immunology, vol.76, pp.22-29, 2015.
, J. TH17 Cells in Immunity and Autoimmunity. Clinical and Developmental Immunology, vol.2013, pp.1-16, 2013.
, Increased frequency of circulating Th22 in addition to TH17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease, Arthritis Res Ther, vol.13, p.166, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00643830
, Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junctional alteration, Thromb Haemost, vol.90, pp.915-920, 2003.
, Mouse CD146/MCAM is a marker of natural killer cell maturation, Eur. J. Immunol, vol.38, pp.2855-2864, 2008.
, MCAM-expressing CD4+ T cells in peripheral blood secrete IL-17A and are significantly elevated in inflammatory autoimmune diseases, Journal of Autoimmunity, vol.37, pp.319-327, 2011.